about
Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization.Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in ratsDevelopment of a purified cholera toxoid. I. Purification of toxinDevelopment of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.Immunological control mechanism against cholera toxin: interference with toxin binding to intestinal receptors.Preparation of a purified antigenic cholera toxoidRadioimmunoassay for the antigenic determinants of cholera toxin and its components.Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.Induction of a mucosal antitoxin response and its role in immunity to experimental canine choleraImmunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge.In vivo suppression of the immune response to alloantigen by cholera enterotoxinVibrio cholerae: lessons for mucosal vaccine design.Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli.Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanismsGenetic mapping of toxin regulatory mutations in Vibrio choleraeProcholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.Evaluation of the biological properties of different classes of human antibodies in relation to cholera.Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.Specific binding of cholera toxin to isolated intestinal microvillous membranes.Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvantsArousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxinProtective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli.
P2860
Q33899855-F20751E4-3A3D-40EA-B52F-EA457E389287Q34076990-50E17093-AC2B-4FEA-938B-8A983A810869Q34079512-51861267-B066-409A-B45F-C7F166E60B70Q34103598-544952FF-7F6E-480D-A93F-0606F8AED807Q34103640-360BAB19-C7E2-416B-BF64-04A6129F1660Q34111109-9A0572DD-26F4-489B-AAC1-2B803F983B30Q34119379-6859F8C8-BDAD-4CF2-9A7A-924E65B2C14EQ34120919-7EFE0878-A0AF-4DEB-94FF-67ABCDA1D346Q34134932-94C1E954-7514-4D3B-B16A-192BBD2CED0EQ34397962-2CB140CB-FD42-44CF-8AB4-F8FF5B798C5DQ34414752-1095DF5D-9091-46E2-8726-E0261A67506CQ34418201-EB409E0C-3A59-4A27-86E3-D9D68FB5B3CAQ34450456-EB4300C7-39D6-4677-8EFF-2C5A8C5AD0AEQ34497051-AF76EA94-EDB5-4225-B96C-2D65E82334C8Q34513669-292C22B0-D149-4DC8-9541-037BA44E6457Q34562952-B1BC6B0C-8A8C-40D3-AD08-47C63F2CDF7BQ36271810-9767A313-9EE2-4A89-A269-C29663876C63Q36331538-60660464-0D03-49B9-9F1C-03CD1B0458CEQ36334127-84EAB3FA-F2B8-4202-B174-CEDC60050D43Q36348710-03620959-3E6E-4B0E-ADD1-E37835C9EE7FQ36421641-0A0FEF7D-D565-49C1-9FDA-BAA806A43598Q36992532-376AA498-E515-47A0-8347-17017088E49EQ37078483-53591059-FD77-4317-AFBE-00B6B63956C5Q37429949-2DC411B4-B73C-44E4-89D3-3F3E41BE04E3Q39509949-B9D865C0-807C-40CF-9E70-B249FBF5C24DQ40598513-34C385A7-DF33-4588-9CD8-24CEA45F271EQ40615931-C43B68DD-968C-4A8A-92EF-7F495E55E138Q40616002-02246E18-A88F-443E-98BD-D53640B6E8F5Q41161713-A39A500D-DFBE-4917-B3E7-58D6CF85BEBC
P2860
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh-hant
name
Protection against experimental cholera by antitoxin.
@en
Protection against experimental cholera by antitoxin.
@nl
type
label
Protection against experimental cholera by antitoxin.
@en
Protection against experimental cholera by antitoxin.
@nl
prefLabel
Protection against experimental cholera by antitoxin.
@en
Protection against experimental cholera by antitoxin.
@nl
P2093
P356
P1476
Protection against experimental cholera by antitoxin.
@en
P2093
Kaniecki EA
Northrup RS
P304
P356
10.1093/INFDIS/126.6.606
P407
P577
1972-12-01T00:00:00Z